Cargando…
THU579 Severe Hypokalemia: Is It Mineralocorticoid Excess Induced By Abiraterone Or Exogenous Hypercortisolism?
Disclosure: D. Katwal: None. B.C. Barreto: None. J. Turner: None. D. James: Research Investigator; Self; Sanofi, Abbvie, Regeneron Pharmaceuticals. Introduction: Abiraterone is a CYP171A1 inhibitor used to treat metastatic, castration-resistant prostate cancer (CRPC). We report a case of severe hypo...
Autores principales: | Katwal, Dilasha, Colon Barreto, Brigida, Turner, James, James, Deirdre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554312/ http://dx.doi.org/10.1210/jendso/bvad114.1723 |
Ejemplares similares
-
THU577 Acth Dependent Cushing Syndrome Identification And Management Challenges
por: Colon Barreto, Brigida, et al.
Publicado: (2023) -
FRI163 Central Role Of Mirnas During Kidney Development And Establishment Of The Mineralocorticoid Signaling Pathway Establishment Of The Mineralocorticoid Signaling Pathway
por: Hani, Imene, et al.
Publicado: (2023) -
OR22-03 Enhanced Endothelial Mineralocorticoid Receptor Signaling Mediates Diet - Induced Soleus Fat Infiltration And Insulin Resistance
por: Homan, Carlton, et al.
Publicado: (2023) -
SUN-020 Analyses Of Clock Gene Expressions In Peripheral Leukocytes In Hypercortisolism
por: Ishiwata, Kazuki, et al.
Publicado: (2019) -
FRI161 An in Vitro Triple Screen Model for Human Mineralocorticoid Receptor Activity
por: Liu, Haiping, et al.
Publicado: (2023)